21.9 C
New York
Thursday, July 3, 2025

Tag: licensing

newssourcecompanyFORcontentinformation1marketbusiness

Gwo Xi Stem Cell Company Powers Local Regenerative Medicine, Partners with Japan to Open a New Era

HSINCHU, July 3, 2025 /PRNewswire/ -- Gwo Xi Stem Cell Applied Technology Co., Ltd. (TPEx: 6704) is a clinical-stage cell therapy company headquartered in...

Blokees Becomes Exclusive Strategic Partner of “Journey of Light: A Glimpse into Ultraman’s 60th Anniversary” Exhibition

SHANGHAI, July 3, 2025 /PRNewswire/ -- On July 2nd, the much-anticipated exhibition "Journey of Light: A Glimpse into Ultraman's 60th Anniversary" hosted its media...

Blokees Becomes Exclusive Strategic Partner of “Journey of Light: A Glimpse into Ultraman’s 60th Anniversary” Exhibition

SHANGHAI, July 2, 2025 /CNW/ -- On July 2nd, the much-anticipated exhibition "Journey of Light: A Glimpse into Ultraman's 60th Anniversary" hosted its media...

Blokees Becomes Exclusive Strategic Partner of “Journey of Light: A Glimpse into Ultraman’s 60th Anniversary” Exhibition

SHANGHAI, July 2, 2025 /PRNewswire/ -- On July 2nd, the much-anticipated exhibition "Journey of Light: A Glimpse into Ultraman's 60th Anniversary" hosted its media...

Blokees Becomes Exclusive Strategic Partner of “Journey of Light: A Glimpse into Ultraman’s 60th Anniversary” Exhibition

SHANGHAI, July 3, 2025 /PRNewswire/ -- On July 2nd, the much-anticipated exhibition "Journey of Light: A Glimpse into Ultraman's 60th Anniversary" hosted its media...

FiEE, Inc. Acquires Advanced Tech Suite Expected to Supercharge IoT-AI Content & Audience Targeting Platform

HONG KONG, July 2, 2025 /PRNewswire/ -- FiEE, Inc. (NASDAQ:MINM) ("FiEE" or the "Company"), a technology company integrating IoT, connectivity and AI to redefine...

Apotex receives Health Canada approval for Aflivu™, a biosimilar to Eylea®, available in pre-filled syringe and vial formats

TORONTO, July 2, 2025 /PRNewswire/ - Apotex Inc. ("Apotex" or the "Company"), the Canadian-based global health company, today announced that Health Canada has approved Aflivu™ (aflibercept),...

High Roller Announces Content Partnership With Gaming Realms in Ontario

Las Vegas, Nevada, July 02, 2025 (GLOBE NEWSWIRE) -- High Roller Technologies (“High Roller” and the “Company”) (NYSE: ROLR), operator of award-winning premium online casino brands High Roller and Fruta, today announced a partnership with Gaming Realms to add its innovative gaming content to the Company’s online casino library in Ontario.

Everest Medicines Announces Updated Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of...

As of March 21st, 2025, longer follow-up data was collected from the ongoing Ph1b/2a study of EVER001: in Cohort 1, 11 patients completed 52...

TGS Awarded Offshore Wind Site Characterization Contract

OSLO, Norway (2 July 2025) – TGS, a global leader in energy data and intelligence today announced the award of a contract for offshore wind site characterization, including acquisition, imaging and interpretation services offshore Norway. Ramform Vanguard will start acquisition in early July, with a duration of approximately 25 days. The imaging and interpretation work will commence concurrently with data acquisition and final data delivery to the client is expected in Q1 2026.

GoldMining Options Up to 80% of the Boa Vista Project to Australian Mines Limited for Total Consideration of Up to $7 million

VANCOUVER, BC, July 1, 2025 /CNW/ - GoldMining Inc. (the "Company" or "GoldMining") (TSX: GOLD) (NYSE American: GLDG) is pleased to announce that its...

GoldMining Options Up to 80% of the Boa Vista Project to Australian Mines Limited for Total Consideration of Up to $7 million

VANCOUVER, BC, July 1, 2025 /PRNewswire/ - GoldMining Inc. (the "Company" or "GoldMining") (TSX: GOLD) (NYSE American: GLDG) is pleased to announce that its...

SAFILO GROUP AND VICTORIA BECKHAM ANNOUNCE A TEN-YEAR GLOBAL LICENSING AGREEMENT FOR EYEWEAR COLLECTIONS

PADUA, Italy and LONDON, July 1, 2025 /PRNewswire/ -- Safilo Group – one of the eyewear industry's key players in the design, manufacturing and distribution...

RedHill Biopharma Announces Recruitment Initiated into Expanded Phase 2 Opaganib/Darolutamide Combination Study in Advanced Prostate Cancer

Recruitment initiated into the Phase 2 opaganib plus darolutamide study in patients with advanced prostate cancer, sponsored by ANZUP, and supported by Bayer and...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsLicensing

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers